Globus Medical Inc
GMED· NYSE
Released Feb 17, 2022, after the close
10-K filed Feb 17, 2022, 48 days after period end · 0001562762-22-000037
derived · Computed from the longer spans the company filed.
| Metric | Q4 2021dderived from reported figures | Q4 2020 | Q4 2019 | Q4 2018 |
|---|---|---|---|---|
| Revenue | $250.02M | $233.45M | $211.67M | $195.94M |
| Net Income | $15.11M | $52.96M | $45.53M | $36.75M |
Globus Medical Inc · CIK 1237831 · Engraved from SEC EDGAR
| EPS Diluted | — | $0.52 | $0.44 | $0.36 |
|---|
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.